Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes

Cellular Oncology

Volumn 31, Issue 1, 2009, Pages 19-29

  Galamb, Orsolya ^a,b   Sipos, Ferenc ^a   Spisák, Sándor ^a   Galamb, Barnabás ^a   Krenács, Tibor ^c   Valcz, Gábor ^a   Tulassay, Zsolt ^a,b   Molnár, Béla ^a,b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Adenoma dysplasia carcinoma sequence; Amnionless homolog; Colorectal cancer; Gene expression signature; Prostaglandin D2 receptor; Tissue microarray; Whole genomic oligonucleo tide microarray

Indexed keywords

BIGLYCAN; BIOLOGICAL MARKER; COLLAGEN; COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA 1; MATRIX PROTEIN; MESSENGER RNA; OSTEONECTIN; PROSTAGLANDIN D2; PROSTAGLANDIN RECEPTOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

AMNIONLESS HOMOLOG GENE; ARTICLE; BIOTINYLATION; CANCER SCREENING; COLON BIOPSY; COLON CARCINOMA; COLON DYSPLASIA; COLORECTAL ADENOMA; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DOWN REGULATION; GASTROINTESTINAL DYSPLASIA; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE MUTATION; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA ISOLATION; SCREENING TEST; SEQUENCE HOMOLOGY; TISSUE MICROARRAY; TUMOR GENE; UPREGULATION; VALIDATION STUDY;

ADENOMA; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 58149379486     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/890349     Document Type: Article

References (42)

1. D. Agrawal, T. Chen, R. Irby et al., Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling, J. Natl. Cancer Inst. 94 (2002), 513-521.
2. D.J. Best and P.G. Gipps, Algorithm AS 71: The upper tail probabilities of Kendall's tau applied statistics, Appl. Statist. 23 (1974), 98-100.
3. K. Birkenkamp-Demtroder, S.H. Olesen, F.B. Sorensen et al., Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid, Gut 54 (2005), 374-384.
4. D. Calistri, C. Rengucci, I. Seymour et al., KRAS, p53 and BRAF gene mutations and aneuploidy in sporadic colorectal cancer progression, Cell. Oncol. 28 (2006), 161-166.
5. Cancer Research Campaign, Cancer Statistics: Large Bowel - UK, CRC, London, 1999.
6. T. Chiba, A. Kanda, S. Ueki et al., Possible novel receptor for PGD2 on human bronchial epithelial cells, Int. Arch. Allergy Immunol. 143(Suppl. 1) (2007), 23-27.
7. R.S. Croner, T. Foertsch, W.M. Brueckl et al., Common denominator genes that distinguish colorectal carcinoma from normal mucosa, Int. J. Colorectal Dis. 20 (2005), 353-362.
8. D.C. Damin, M.A. Rosito, P. Gus et al., Von Willebrand factor in colorectal cancer, Int. J. Colorectal Dis. 17 (2002), 42-45.
9. S. Derks, C. Postma, P.T. Moerkerk et al., Promoter methylation precedes chromosomal alterations in colorectal cancer development, Cell. Oncol. 28 (2006), 247-257.
10. J.C. Fyfe, M. Madsen, P. Højrup et al., The functional cobalamin (vitamin B12)-intrinsic factor receptor is a novel complex of cubilin and amnionless, Blood 103 (2004), 1573-1579.
11. O. Galamb, B. Gyorffy, F. Sipos et al., Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature, Dis. Markers 25 (2008), 1-16.
12. O. Galamb, F. Sipos, E. Dinya et al., mRNA expression, functional profiling and multivariate classification of colon biopsy specimen by cDNA overall glass microarray, World J. Gastroenterol. 12 (2006), 6998-7006.
13. O. Galamb, F. Sipos, K. Fischer et al., The results of the expression array studies correlate and enhance the known genetic basis of gastric and colorectal cancer, Cytometry B Clin. Cytom. 68 (2005), 1-17.
14. O. Galamb, F. Sipos, B. Molnar et al., Evaluation of malignant and benign gastric biopsy specimens by mRNA expression profile and multivariate statistical methods, Cytometry B Clin. Cytom. 72 (2007), 299-309.
15. M. Guba, H. Seeliger, A. Kleespies et al., Vascular endothelial growth factor in colorectal cancer, Int. J. Colorectal Dis. 19 (2004), 510-517.
16. G. Hawcroft, S.H. Gardner and M.A. Hull, Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cells, Cancer Lett. 210 (2004), 81-84.
17. D.M. Heijink, J.H. Kleibeuker, M. Jalving et al., Independent induction of caspase-8 and cFLIP expression during colorectal carcinogenesis in sporadic and HNPCC adenomas and carcinomas, Cell. Oncol. 29 (2007), 409-419.
18. M.N. Holten-Andersen, I.J. Christensen, H.J. Nielsen et al., Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer, Clin. Cancer Res. 8 (2002), 156-164.
19. S. Kalantry, S. Manning, O. Haub et al., The amnionless gene, essential for mouse gastrulation, encodes a visceral-endoderm-specific protein with an extracellular cysteine-rich domain, Nat. Genet. 27 (2001), 351-352.
20. K.Y. Kwong, G.C. Bloom, I. Yang et al., Synchronous global assessment of gene and protein expression in colorectal cancer progression, Genomics 86 (2005), 142-158.
21. S. Lee, Bang, K. Song et al., Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon, Oncol. Rep. 16 (2006), 747-754.
22. A. Leslie, F.A. Carey, N.R. Pratt et al., The colorectal adenoma-carcinoma sequence, Br. J. Surg. 89 (2002), 845-860.
23. M. Li, Y.M. Lin, S. Hasegawa et al., Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray, Int. J. Oncol. 24 (2004), 305-312.
24. Y.M. Lin, Y. Furukawa, T. Tsunoda et al., Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas, Oncogene 21 (2002), 4120-4128.
25. D. Meyer, A. Zeileis and K. Hornik, The strucplot framework: Visualizing multi-way contingency tables with 'vcd', J. Stac. Software 17 (2006), 1-48.
26. D. Mori, Y. Nakafus, K. Miyazaki et al., Differential expression of Janus kinase 3 (JAK3), matrix metalloproteinase 13 (MMP13), heat shock protein 60 (HSP60), and mouse double minute 2 (MDM2) in human colorectal cancer progression using human cancer cDNA microarrays, Pathol. Res. Pract. 201 (2005), 777-789.
27. K. Nosho, H. Yamamoto, Y. Adachi et al., Gene expression profiling of colorectal adenomas and early invasive carcinomas by cDNA array analysis, Br. J. Cancer 92 (2005), 1193-1200.
28. K. Nosho, H. Yamamoto, H. Takamaru et al., A case of colorectal carcinoma in adenoma analyzed by a cDNA array, Int. J. Colorectal Dis. 20 (2005), 287-291.
29. K. Nosho, H. Yamamoto, H. Taniguchi et al., Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis, Clin. Cancer Res. 10 (2004), 7950-7957.
30. D.A. Notterman, U. Alon, A.J. Sierk et al., Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays, Cancer Res. 61 (2001), 3124-3130.
31. A.J. Oates, R. Barraclough and P.S. Rudland, The role of osteopontin in tumorigenesis and metastasis, Inv. Metastasis 17 (1997), 1-15.
32. K. Okuno, M. Yasutomi, N. Nishimura et al., Gene expression analysis in colorectal cancer using practical DNA array filter, Dis. Colon Rectum 44 (2001), 295-299.
33. R. Patarca, R.A. Saavedra and H. Cantor, Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene, Crit. Rev. Immunol. 13 (1993), 225-246.
34. H. Porte, E. Chastre, S. Prevot et al., Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes, Int. J. Cancer 64 (1995), 70-75.
35. J. Sabates-Bellver, L.G. Van der Flier, M. de Palo et al., Transcriptome profile of human colorectal adenomas, Mol. Cancer Res. 5 (2007), 1263-1275.
36. P. Schratl, J.F. Royer, E. Kostenis et al., The role of the prostaglandin D2 receptor, DP, in eosinophil trafficking, J. Immunol. 179 (2007), 4792-4799.
37. J. Sodek, B. Zhu, M.H. Huynh et al., Novel functions of the matricellular proteins osteopontin and osteonectin/SPARC, Connect. Tissue Res. 43 (2002), 308-319.
38. I. Takemasa, H. Higuchi, H. Yamamoto et al., Construction of preferential cDNA microarray specialized for human colorectal carcinoma: molecular sketch of colorectal cancer, Biochem. Biophys. Res. Commun. 285 (2001), 1244-1249.
39. Tumor Analysis Best Practices Working Group, Expression profiling-best practices for data generation and interpretation in clinical trials, Nat. Rev. Genet. 5 (2004), 229-237.
40. L.G. Van der Flier, J. Sabates-Bellver, I. Oving et al., The intestinal Wnt/TCF signature, Gastroenterology 132 (2007), 628-632.
41. B. Vogelstein, E.R. Fearon, S.R. Hamilton et al., Genetic alterations during colorectal-tumor development, N. Engl. J. Med. 319 (1988), 525-532.
42. Y. Wen, S.F. Giardina, D. Hamming et al., GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1, Clin. Cancer Res. 12 (2006), 5951-5959.